• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sapiens Reports Second Quarter 2023 Financial Results

    8/2/23 6:21:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SPNS alert in real time by email

    HOLON, Israel, Aug. 2, 2023 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2023.

     

    Sapiens Logo

     

    Summary Results for Second Quarter 2023 (USD in millions, except per share data)



    GAAP



    Non-GAAP





    Q2 2023

    Q2 2022

    % Change

    Q2 2023

    Q2 2022

    % Change

    Revenue

    $128.3

    $118.6

    8.2 %

    $128.4

    $118.6

    8.2 %

    Gross Profit

    $54.7

    $50.2

    9.0 %

    $58.0

    $53.2

    9.0 %

    Gross Margin

    42.6 %

    42.3 %

    30 bps

    45.2 %

    44.9 %

     30 bps

    Operating Income

    $19.6

    $16.9

    16.0 %

    $23.4

    $20.7

    12.9 %

    Operating Margin

    15.3 %

    14.3 %

     100 bps

    18.2 %

    17.5 %

     70 bps

    Net Income (*)

    $15.4

    $11.9

    29.3 %

    $18.6

    $15.0

    24.2 %

    Diluted EPS

    $0.28

    $0.21

    33.3 %

    $0.33

    $0.27

    22.2 %



    (*) Attributable to Sapiens' shareholders

     

    "Sapiens achieved a strong second quarter, with 8.2% revenue growth and 18.2% operating margin, driven by significant growth in North American and European markets," stated Roni Al-Dor, President and CEO of Sapiens. "In the second quarter, our North American revenue growth exceeded 8%, and EMEA revenue increased by over 5%. Our Life business is globally successful, fueled by strategic investments in CoreSuite for Life. Sapiens CoreSuite for Life recently won the 2023 Celent XCelent Award in the EMEA region and was recognized as a "Luminary" Policy Administration Solution in EMEA and North America. We recently announced that Sapiens will integrate Microsoft Azure OpenAI and Azure Power Virtual Agents to provide generative AI solutions for insurance companies."

    "Today, we are raising our full-year Non-GAAP revenue guidance for 2023 from $507 - $512 million to $511 - $516 million. We are also increasing the lower range of our operating margin from 17.8% to 18%. Our full-year Non-GAAP operating margin guidance for 2023 is 18.0% - 18.2%," added Mr. Al-Dor.

    "We announced today that the board of directors has approved the distribution of a cash dividend of $0.26 per share, or $14.4 million in total for the first six months of 2023." concluded Mr. Al-Dor.

    The dividend will be paid on August 30, 2023, to Sapiens' shareholders of record as of August 16, 2023.

    The dividend is subject to withholding of Israeli tax at source at the rate of 25% of the dividend amount payable to Israeli individual, and non-Israeli, shareholders of record."

    Quarterly Results Conference Call

    Management will host a conference call and webcast on August 2, 2023, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

         North America (toll-free): 1-888-642-5032

         International: 972-3-9180609

         UK: 0-800-917-5108

    The live webcast of the call can be viewed on Sapiens' website at: veidan.activetrail.biz/sapiensq2-2023. A replay of the call will be available one business day following the completion of the event at the same link for 90 days.

    Non-GAAP Financial Measures

    This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

    Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

    Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

    Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

    To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

    Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

    The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

    The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

    About Sapiens

    Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. With more than 40 years of industry expertise, Sapiens' cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data and digital domains to accelerate our customers' digital transformation. Serving over 600 customers in more than  30 countries, Sapiens offers insurers across property and casualty, workers' compensation, and life insurance markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit www.sapiens.com or follow us on LinkedIn.

    Investor and Media Contact

     

    Yaffa Cohen-Ifrah

    Chief Marketing Officer and Head of

    Investor Relations, Sapiens

    [email protected]

    +1 917-533-4782

    Investor Contacts

    Brett Maas

    Managing Partner, Hayden IR

    +1 646-536-7331

    [email protected]

    Kimberly Rogers

    Managing Director, Hayden IR

    +1 541-904-5075

    [email protected]

     

    Forward Looking Statements

    Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENT OF INCOME

    U.S. dollars in thousands (except per share amounts)









    Three months ended 



    Six months ended







     June 30,



     June 30,







    2023



    2022



    2023



    2022







    (unaudited)



    (unaudited)



    (unaudited)



    (unaudited)





















     Revenue



    128,299



    118,582



    253,020



    236,277

     Cost of revenue



    73,635



    68,416



    145,327



    136,694





















     Gross profit



    54,664



    50,166



    107,693



    99,583





















     Operating expenses:



















     Research and development, net



    15,746



    14,451



    31,363



    28,601



     Selling, marketing, general and administrative



    19,297



    18,805



    37,816



    37,524

     Total operating expenses



    35,043



    33,256



    69,179



    66,125





















     Operating income



    19,621



    16,910



    38,514



    33,458





















     Financial and other expenses, net



    562



    2,467



    1,759



    2,119

     Taxes on income



    3,587



    2,512



    6,917



    5,450









































     Net income



    15,472



    11,931



    29,838



    25,889





















     Attributable to non-controlling interest



    69



    21



    239



    53





















     Net income attributable to Sapiens' shareholders



    15,403



    11,910



    29,599



    25,836









































     Basic earnings per share



    0.28



    0.22



    0.54



    0.47





















     Diluted earnings per share



    0.28



    0.21



    0.53



    0.46







































    Weighted average number of shares outstanding used to

    compute basic earnings per share (in thousands)



    55,196



    55,110



    55,176



    55,101



















    Weighted average number of shares outstanding used to

    compute diluted earnings per share (in thousands)



    55,582



    55,572



    55,576



    55,602

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

    RECONCILIATION OF GAAP TO NON-GAAP RESULTS

    U.S. dollars in thousands (except per share amounts)







    Three months ended



    Six months ended





    June 30,



    June 30,





    2023



    2022



    2023



    2022





    (unaudited)



    (unaudited)



    (unaudited)



    (unaudited)



















    GAAP revenue



    128,299



    118,582



    253,020



    236,277

    Valuation adjustment on acquired deferred

    revenue



    55



    23



    110



    45

    Non-GAAP revenue



    128,354



    118,605



    253,130



    236,322



















    GAAP gross profit



    54,664



    50,166



    107,693



    99,583

    Revenue adjustment



    55



    23



    110



    45

    Amortization of capitalized software



    1,425



    1,410



    2,856



    2,881

    Amortization of other intangible assets



    1,848



    1,608



    3,696



    3,640

    Non-GAAP gross profit



    57,992



    53,207



    114,355



    106,149



















    GAAP operating income



    19,621



    16,910



    38,514



    33,458

    Gross profit adjustments



    3,328



    3,041



    6,662



    6,566

    Capitalization of software development



    (1,679)



    (1,621)



    (3,337)



    (3,367)

    Amortization of other intangible assets



    1,084



    1,155



    2,160



    2,399

    Stock-based compensation



    1,059



    1,129



    1,922



    2,060

    Acquisition-related costs *)



    4



    133



    10



    400

    Non-GAAP operating income



    23,417



    20,747



    45,931



    41,516



















    GAAP net income attributable to Sapiens'

    shareholders



    15,403



    11,910



    29,599



    25,836

    Operating income adjustments



    3,796



    3,837



    7,417



    8,058

    Taxes on income



    (589)



    (768)



    (1,153)



    (1,618)

    Non-GAAP net income attributable to

    Sapiens' shareholders



    18,610



    14,979



    35,863



    32,276



     (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and

    retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

     

     

    Adjusted EBITDA Calculation

    U.S. dollars in thousands







    Three months ended



    Six months ended





     June 30,



     June 30,





    2023



    2022



    2023



    2022



















    GAAP operating profit



    19,621



    16,910



    38,514



    33,458



















    Non-GAAP adjustments:

















    Valuation adjustment on acquired deferred

    revenue



    55



    23



    110



    45

    Amortization of capitalized software



    1,425



    1,410



    2,856



    2,881

    Amortization of other intangible assets



    2,932



    2,763



    5,856



    6,039

    Capitalization of software development



    (1,679)



    (1,621)



    (3,337)



    (3,367)

    Stock-based compensation



    1,059



    1,129



    1,922



    2,060

    Compensation related to acquisition and acquisition-

    related costs



    4



    133



    10



    400



















    Non-GAAP operating profit



    23,417



    20,747



    45,931



    41,516



















    Depreciation



    976



    934



    2,031



    2,075



















    Adjusted EBITDA



    24,393



    21,681



    47,962



    43,591

     

     

    Summary of NON-GAAP Financial Information 

    U.S. dollars in thousands (except per share amounts)





    Q2 2023



    Q1 2023



    Q4 2022



    Q3 2022



    Q2 2022





















    Revenues

    128,354



    124,776



    119,486



    119,019



    118,605

    Gross profit

    57,992



    56,363



    53,774



    53,546



    53,207

    Operating income

    23,417



    22,514



    21,058



    20,902



    20,747

    Adjusted EBITDA

    24,393



    23,569



    22,092



    22,036



    21,681

    Net income to Sapiens' shareholders

    18,610



    17,253



    18,022



    16,871



    14,979





















    Diluted earnings per share

    0.33



    0.31



    0.32



    0.30



    0.27

     

     

    Non-GAAP Revenues by Geographic Breakdown

    U.S. dollars in thousands





    Q2 2023



    Q1 2023



    Q4 2022



    Q3 2022



    Q2 2022





















    North America

    52,116



    50,371



    50,801



    49,555



    48,154

    Europe

    62,960



    64,572



    56,910



    56,887



    59,868

    Rest of the World

    13,278



    9,833



    11,775



    12,577



    10,583





















    Total

    128,354



    124,776



    119,486



    119,019



    118,605

     

     

    Non-GAAP Revenue breakdown

    U.S. dollars in thousands





    Three months ended



    Six months ended



    June 30,



    June 30,



    2023



    2022



    2023



    2022

















    Software products and re-occurring post-production services (*)

    82,559



    71,965



    164,401



    147,589

    Pre-production implementation services (**)

    45,795



    46,640



    88,729



    88,733

















    Total Revenues

    128,354



    118,605



    253,130



    236,322

















     

     



    Three months ended



    Six months ended



    June 30,



    June 30,



    2023



    2022



    2023



    2022

















    Software products and re-occurring post-production services (*)

    42,437



    37,599



    87,286



    78,045

    Pre-production implementation services (**)

    15,555



    15,608



    27,069



    28,104

















    Total Gross profit

    57,992



    53,207



    114,355



    106,149





     

     



    Three months ended



    Six months ended



    June 30,



    June 30,



    2023



    2022



    2023



    2022

















    Software products and re-occurring post-production services (*)

    51.4 %



    52.2 %



    53.1 %



    52.9 %

    Pre-production implementation services (**)

    34.0 %



    33.5 %



    30.5 %



    31.7 %

















    Gross Margin

    45.2 %



    44.9 %



    45.2 %



    44.9 %

    (*) Software products and re-occurring post-production services include mainly term license, maintenance, cloud solutions, subscription, and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.

    (**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

     

     

    Adjusted Free Cash-Flow

    U.S. dollars in thousands





    Q2 2023



    Q1 2023



    Q4 2022



    Q3 2022



    Q2 2022





















    Cash-flow from operating activities

    14,603



    22,188



    14,430



    4,405



    6,615

    Increase in capitalized software development costs

    (1,679)



    (1,658)



    (1,238)



    (1,492)



    (1,621)

    Capital expenditures

    (775)



    (634)



    (400)



    (1,047)



    (803)

    Free cash-flow

    12,149



    19,896



    12,792



    1,866



    4,191





















    Cash payments attributed to acquisition-related

    costs(*) (**)

    -



    30



    1,100



    -



    -





















    Adjusted free cash-flow

    12,149



    19,926



    13,892



    1,866



    4,191





    (*) Included in cash-flow from operating activities



    (**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets

    and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEET

    U.S. dollars in thousands



















    June 30,



    December 31,







    2023



    2022







     (unaudited)



     (unaudited)













     ASSETS























     CURRENT ASSETS











    Cash and cash equivalents



    89,417



    160,285



    Short-term bank deposit



    90,000



    20,000



    Trade receivables, net and unbilled receivables



    89,338



    93,382



    Other receivables and prepaid expenses



    14,539



    11,640















    Total current assets



    283,294



    285,307













     LONG-TERM ASSETS











    Property and equipment, net



    11,453



    12,021



    Severance pay fund



    3,696



    3,996



    Goodwill and intangible assets, net



    312,474



    319,661



    Operating lease right-of-use assets



    25,264



    33,688



    Other long-term assets



    16,864



    13,671















    Total long-term assets



    369,751



    383,037













     TOTAL ASSETS



    653,045



    668,344













    LIABILITIES AND EQUITY





















     CURRENT LIABILITIES











    Trade payables



    8,475



    9,415



    Current maturities of Series B Debentures



    19,796



    19,796



    Accrued expenses and other liabilities



    68,553



    76,962



    Current maturities of operating lease liabilities



    7,463



    9,063



    Deferred revenue



    36,275



    30,720















    Total current liabilities



    140,562



    145,956













     LONG-TERM LIABILITIES











    Series B Debentures, net of current maturities



    39,511



    59,275



    Deferred tax liabilities



    12,218



    11,363



    Other long-term liabilities



    12,728



    13,312



    Long-term operating lease liabilities



    22,037



    28,432



    Redeemable non-controlling interest



    85



    89



    Accrued severance pay



    7,223



    7,063















    Total long-term liabilities



    93,802



    119,534













    EQUITY





    418,681



    402,854













    TOTAL LIABILITIES AND EQUITY



    653,045



    668,344











     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENT OF CASH FLOW

    U.S. dollars in thousands



    For the six months ended June 30,



    2023



    2022



    (unaudited)



    (unaudited)

    Cash flows from operating activities:







    Net income

    29,838



    25,889

    Reconciliation of net income to net cash provided by operating activities:







    Depreciation and amortization

    10,743



    10,995

    Accretion of discount on Series B Debentures

    32



    42

    Capital (gain) loss from sale of property and equipment

    86



    36

    Stock-based compensation related to options issued to employees

    1,922



    2,060









    Net changes in operating assets and liabilities, net of amount acquired:







    Decrease (increase) in trade receivables, net and unbilled receivables

    2,351



    (10,758)

    Increase (decrease) in deferred tax liabilities, net

    45



    (607)

    Decrease (increase) in other operating assets

    (390)



    4,151

    Increase (decrease) in trade payables

    (1,014)



    7,035

    Increase (decrease) in other operating liabilities

    (12,572)



    (10,662)

    Increase in deferred revenues

    5,284



    (3,090)

    Increase in accrued severance pay, net

    466



    (146)









    Net cash provided by operating activities

    36,791



    24,945









    Cash flows from investing activities:







    Purchase of property and equipment

    (1,439)



    (1,265)

    Investment in deposits

    (70,002)



    (15,160)

    Proceeds from sale of property and equipment

    30



    9

    Proceeds from (payments for) business acquisitions, net of cash acquired

    -



    (3,467)

    Capitalized software development costs

    (3,337)



    (3,367)

    Acquisition of intellectual property

    (177)



    -









    Net cash provided by (used in) investing activities

    (74,925)



    (23,250)









    Cash flows from financing activities:







    Distribution of dividend

    (13,796)



    (25,900)

    Repayment of Series B Debenture

    (19,796)



    (19,796)

    Dividend to non-controlling interest

    (47)



    -









    Net cash used in financing activities

    (33,639)



    (45,696)









    Effect of exchange rate changes on cash and cash equivalents

    905



    (5,113)









    Decrease in cash and cash equivalents

    (70,868)



    (49,114)

    Cash and cash equivalents at the beginning of period

    160,285



    190,243









    Cash and cash equivalents at the end of period

    89,417



    141,129

     

    Debentures Covenants

    As of June 30, 2023, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

    Covenant 1 

    • Target shareholders' equity (excluding non-controlling interest): above $120 million.
    • Actual shareholders' equity (excluding non-controlling interest) equal to $416.2 million.

    Covenant 2

    • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
    • Actual ratio of net financial indebtedness to net capitalization equal to (39.76)%.

    Covenant 3

    • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
    • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.29).

    Logo - http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

    Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-second-quarter-2023-financial-results-301891413.html

    SOURCE Sapiens International Corporation

    Get the next $SPNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPNS

    DatePrice TargetRatingAnalyst
    2/3/2025$36.00 → $28.00Buy → Hold
    Jefferies
    5/5/2023$24.00Equal Weight → Underweight
    Barclays
    1/23/2023$28.00Buy
    Goldman
    12/1/2022$20.00Underweight
    JP Morgan
    2/24/2022$38.00 → $30.00Buy
    Citigroup
    2/24/2022$40.00 → $36.00Buy
    Needham
    12/14/2021Neutral → Underweight
    JP Morgan
    12/14/2021$35.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SPNS
    SEC Filings

    View All

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:47:01 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:45:43 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:44:28 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sapiens Int'l downgraded by Jefferies with a new price target

    Jefferies downgraded Sapiens Int'l from Buy to Hold and set a new price target of $28.00 from $36.00 previously

    2/3/25 7:11:09 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Int'l downgraded by Barclays with a new price target

    Barclays downgraded Sapiens Int'l from Equal Weight to Underweight and set a new price target of $24.00

    5/5/23 7:20:13 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Goldman initiated coverage on Sapiens Int'l with a new price target

    Goldman initiated coverage of Sapiens Int'l with a rating of Buy and set a new price target of $28.00

    1/23/23 7:48:42 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sapiens Announces Leadership Appointments Following Closing of Acquisition by Advent

    Acquisition supports Sapiens' long-term growth, innovation and global expansionAfter twenty years leading Sapiens, Roni Al-Dor has decided to step down as CEO and PresidentNew leadership appointments to support the next phase of transformationLONDON, Dec. 17, 2025 /PRNewswire/ -- Sapiens International Corporation N.V. ("Sapiens") today announces a series of senior leadership appointments that will support the company's next phase of transformation and global growth. These appointments follow the successful closing of Sapiens' acquisition by Advent, a leading global private equity investor. The transaction was first announced on August 13, 2025, was approved by Sapiens shareholders at the Ext

    12/17/25 12:34:00 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Reports Third Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Nov. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2025. Summary Results for Third Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q3 2025 Q3 2024  % Change Q3 2025 Q3 2024 % Change Revenue $ 152.3 $ 137.0 11.2 % $ 152.3 $ 137.0 11.2 % Gross Profit $ 67.3 $ 60.3 11.6 % $ 70.7 $ 62.8 12.5 % Gross Margin 44.2 % 44.0 %  20 bps 46.4 % 45.8 % 60 bps Operating Income $ 17.8 $ 21.7 -18.3 % $ 25.5 $ 25.1 1.5 % Operating Margin 11.7 % 15.9 %  -420 bps 16.7 % 18.3

    11/13/25 5:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SAPIENS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025

    ROCHELLE PARK, N.J., Nov. 6, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Third quarter of 2025 on Thursday November 13, 2025. On August 12, 2025, Sapiens announced that it entered into a definitive agreement to be acquired by Advent, a leading global private equity investor, for $43.50 per common share in cash, valuing Sapiens at approximately $2.5 billion. About SapiensSapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS) is a global leader in intelligent SaaS-based software solutions. With Sapiens' robus

    11/6/25 7:40:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Financials

    Live finance-specific insights

    View All

    Sapiens Reports Third Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Nov. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2025. Summary Results for Third Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q3 2025 Q3 2024  % Change Q3 2025 Q3 2024 % Change Revenue $ 152.3 $ 137.0 11.2 % $ 152.3 $ 137.0 11.2 % Gross Profit $ 67.3 $ 60.3 11.6 % $ 70.7 $ 62.8 12.5 % Gross Margin 44.2 % 44.0 %  20 bps 46.4 % 45.8 % 60 bps Operating Income $ 17.8 $ 21.7 -18.3 % $ 25.5 $ 25.1 1.5 % Operating Margin 11.7 % 15.9 %  -420 bps 16.7 % 18.3

    11/13/25 5:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Reports Second Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025. Summary Results for Second Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q2 2025 Q2 2024 % Change Q2 2025 Q2 2024 % Change Revenue $141.6 $136.8 3.5 % $141.6 $136.8 3.5 % Gross Profit $61.9 $60.1 3.0 % $64.8 $62.5 3.8 % Gross Margin 43.7 % 43.9 %  -20 bps 45.8 % 45.7 % 10 bps Operating Income $16.8 $21.9 -23.2 % $23.1 $24.8 -7.1 % Operating Margin 11.9 % 16.0 %  -410 bps 16.3 % 18.2 % -190 bps Net Inc

    8/13/25 7:15:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SAPIENS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 13, 2025

    ROCHELLE PARK, N.J., July 23, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Second quarter of 2025 on Wednesday, August 13, 2025. Management will host a conference call and webcast on August 13, 2025, at 11:30 a.m. Eastern Time (6:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): 1-888-642-5032 International: 972-3-9180608 UK: 0-808-101-2717 The live webcast of the call can be access

    7/23/25 7:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Leadership Updates

    Live Leadership Updates

    View All

    Sapiens Announces Leadership Appointments Following Closing of Acquisition by Advent

    Acquisition supports Sapiens' long-term growth, innovation and global expansionAfter twenty years leading Sapiens, Roni Al-Dor has decided to step down as CEO and PresidentNew leadership appointments to support the next phase of transformationLONDON, Dec. 17, 2025 /PRNewswire/ -- Sapiens International Corporation N.V. ("Sapiens") today announces a series of senior leadership appointments that will support the company's next phase of transformation and global growth. These appointments follow the successful closing of Sapiens' acquisition by Advent, a leading global private equity investor. The transaction was first announced on August 13, 2025, was approved by Sapiens shareholders at the Ext

    12/17/25 12:34:00 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Appoints Jamie Yoder as North America President and General Manager

    HOLON, Israel, April 26, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the appointment of Jamie Yoder as President and General Manager of Sapiens North America. Mr. Yoder's depth of leadership experience in the insurance and technology sectors, including senior management positions at top global professional services firms (such as PwC), will further strengthen Sapiens' footprint, strategy, and operations in North America and globally. Sapiens will benefit from his strong acumen across various touchpoints within the insurance life cycle, especially in these times

    4/26/21 9:58:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    1/17/23 6:12:29 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    7/28/22 6:03:57 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    2/7/22 6:08:41 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology